Obach RS - Search Results

1

The prediction of human clearance from hepatic microsomal metabolism data.

Obach RS. Obach RS. Curr Opin Drug Discov Devel. 2001 Jan;4(1):36-44. Curr Opin Drug Discov Devel. 2001. PMID: 11727321 Review.

2

In vitro metabolism of irosustat, a novel steroid sulfatase inhibitor: interspecies comparison, metabolite identification, and metabolic enzyme identification.

Ventura V, Solà J, Celma C, Peraire C, Obach R. Ventura V, et al. Drug Metab Dispos. 2011 Jul;39(7):1235-46. doi: 10.1124/dmd.111.038315. Epub 2011 Apr 4. Drug Metab Dispos. 2011. PMID: 21464173

3

In vitro evaluation of the interaction potential of irosustat with drug-metabolizing enzymes.

Ventura V, Solà J, Peraire C, Brée F, Obach R. Ventura V, et al. Drug Metab Dispos. 2012 Jul;40(7):1268-78. doi: 10.1124/dmd.111.044271. Epub 2012 Mar 26. Drug Metab Dispos. 2012. PMID: 22451700

4

Nonspecific binding to microsomes: impact on scale-up of in vitro intrinsic clearance to hepatic clearance as assessed through examination of warfarin, imipramine, and propranolol.

Obach RS. Obach RS. Drug Metab Dispos. 1997 Dec;25(12):1359-69. Drug Metab Dispos. 1997. PMID: 9394025

5

Expression and characterization of canine cytochrome P450 2D15.

Roussel F, Duignan DB, Lawton MP, Obach RS, Strick CA, Tweedie DJ. Roussel F, et al. Among authors: obach rs. Arch Biochem Biophys. 1998 Sep 1;357(1):27-36. doi: 10.1006/abbi.1998.0801. Arch Biochem Biophys. 1998. PMID: 9721180

6

Metabolic characterization of the major human small intestinal cytochrome p450s.

Obach RS, Zhang QY, Dunbar D, Kaminsky LS. Obach RS, et al. Drug Metab Dispos. 2001 Mar;29(3):347-52. Drug Metab Dispos. 2001. PMID: 11181505

7

(R)-, (S)-, and racemic fluoxetine N-demethylation by human cytochrome P450 enzymes.

Margolis JM, O'Donnell JP, Mankowski DC, Ekins S, Obach RS. Margolis JM, et al. Among authors: obach rs. Drug Metab Dispos. 2000 Oct;28(10):1187-91. Drug Metab Dispos. 2000. PMID: 10997938

8

Pharmacokinetics of ezlopitant, a novel non-peptidic neurokinin-1 receptor antagonist in preclinical species and metabolite kinetics of the pharmacologically active metabolites.

Reed-Hagen AE, Tsuchiya M, Shimada K, Wentland JA, Obach RS. Reed-Hagen AE, et al. Among authors: obach rs. Biopharm Drug Dispos. 1999 Dec;20(9):429-39. doi: 10.1002/1099-081x(199912)20:9<429::aid-bdd209>3.0.co;2-d. Biopharm Drug Dispos. 1999. PMID: 10951432

9

Metabolism of ezlopitant, a nonpeptidic substance P receptor antagonist, in liver microsomes: enzyme kinetics, cytochrome P450 isoform identity, and in vitro-in vivo correlation.

Obach RS. Obach RS. Drug Metab Dispos. 2000 Sep;28(9):1069-76. Drug Metab Dispos. 2000. PMID: 10950851

10

Inhibition of human cytochrome P450 enzymes by constituents of St. John's Wort, an herbal preparation used in the treatment of depression.

Obach RS. Obach RS. J Pharmacol Exp Ther. 2000 Jul;294(1):88-95. J Pharmacol Exp Ther. 2000. PMID: 10871299

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results